-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Adverse Drug Reactions in the Elderly
Potential Harms From Polypharmacy in the Elderly (BBC News / Age UK / EJCP / Bazian / Lancet Psychiatry)
Summary An Age UK report investigates the potential harms of over-prescribing medicines for older people. Older persons often remain on too many prescribed medicines, putting them at risk of side-effects, potentially resulting in falls and other forms of serious harm. … Continue reading →
Posted in Age UK, Antipsychotics, BBC News, Charitable Bodies, Commissioning, Community Care, Depression, Falls, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Hypertension, In the News, Integrated Care, Management of Condition, National, Personalisation, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged Achieving Better Value, Addictions Department - Division of Academic Psychiatry: King's College London, Addictive Prescription Medicines, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Ageing Population, Alcohol Drugs Tobacco and Justice Division: Public Health England, AntiCholinergic Burden, Anticholinergic Drugs, Anticholinergics, Antidepressants, Anxiolytics and Hypnotics (Including Benzodiazepines), ARMOUR Tool, Australian Prescribing Indicators, Austrian Criteria, Barenholtz Levy, Bazian, BBC Health News, Beers Criteria, Behind the Headlines, Benzodiazepines, Better Value, Better Value Healthcare, Better Value in the NHS, Brown Model, Cantrill Indicators, Care Home Pharmacists, Care Home Pharmacists to Cut Overmedication, Care Homes, Care of Frail Older People With Complex Needs, Care of Older People Living at Home, Care of Older People Living in Care Homes, Care Planning: Relating New Prescribing Decisions to Existing Medicines, Care Quality Improvement Department: Royal College of Physicians, Case Management and Enhanced Rapid Response, Challenging Behaviour in Dementia, Choosing Wisely, Choosing Wisely in the NHS, Choosing Wisely in the UK, Clinical Pharmacists, CMS List, Communication Between Community Pharmacists and GPs, Community Pharmacies, Community Pharmacists, Community Pharmacy, Community-Based Services, Community-Based Support, Comorbidity, Comorbidity and Dementia, Comorbidity and Polypharmacy in People With Dementia, Dementia Friendly Community Pharmacists, Department of Family Medicine: University of California Los Angeles, Department of Primary Care and Public Health: Imperial College London, Dependence and Withdrawal Associated With Prescribed Medicines (PHE Review), Deprescribing, Discontinuation of Multiple Medications in Older Adults, Doubling-Up, Drug Burden Index, Drug Cost Savings, Economic Sustainability, Elderly Malnutrition, European Journal of Clinical Pharmacology, FORTA Criteria, Four or More Medicines (FOMM) Support Service, Frail Older People, Frailty, Gabapentinoids, Geriatric Medication Algorithm, German PRISCUS List of Potentially Inappropriate Medications, Good Practice in Care Homes, Guy's and St Thomas' NHS Foundation Trust, Hamdy Criteria, Hanoi Medical University, Harms of Too Much Medicine, Health Improvement Directorate: Public Health England, High Quality Medicines Reviews, Holmes Criteria, Hospital Pharmacists, Hospital‑Based Multidisciplinary Teams: Pharmacists, Hull-York Medical School: University of Hull, Imperial College London, Improving Care for Frail Older People, Improving Patient Safety, Improving Pharmaceutical Care in Care Homes, Improving Prescribing in the Elderly Tool, Improving Prescribing Practice, Improving Standards in Care Homes, Inappropriate Drug Use, Inappropriate Medication, Inappropriate Prescribing, Institute of Psychiatry Psychology and Neuroscience: King’s College London, Integrated Care Clinical Pharmacist (ICP) for Frail Older People, Integrated Care Pharmacists (ICPs), Kaiser Permanente Model, Kings College London, KPC Criteria, Lambeth Addictions: South London and Maudsley NHS Mental Health Foundation Trust, Lancet Psychiatry, Laroche Criteria, Later Life, Lechevallier Criteria, Less is More, Liaison and In-Reach Services for Frail Older People, Lindblad’s List, Lipton’s Tool, Living at Home, Living Well in Care Homes, Long-Term Conditions (LTCs), Lowering Costs, Maio Criteria, Malnutrition, Malnutrition in Later Life, Malone’s List, Management of Challenging Behaviour, Managing Comorbidity and Complexity, Managing Medicines in Care Homes, Matsumura Alert System, McLeod Criteria, MDTs: Multidisciplinary Teams, Medical Overuse, Medication Adherence, Medication Appropriateness Index, Medication Creep, Medication Nonadherence, Medication Reviews, Medication Reviews in Care Homes, Medication Without Harm (WHO), Medication-Related Harm, Medications Management Outcome Monitor, Medicine Combinations, Medicines Management, Multi-Morbidities, Multimorbidities and Long-Term Conditions, Multiple Comorbidities, Multiple Long-Term Conditions, Multiple Medications (Polypharmacy), National Guideline Centre: Royal College of Physicians, NCOA Criteria, New Mexico Criteria, NHS Business Services Authority (NHSBSA), NHS Community Pharmacies, Non-Adherence: Medication-Related Harm, Norwegian General Practice (NORGEP) Criteria, Oborne’s Prescribing Indicators, Older Adults Higher Levels of Dependency Dementia and Comorbidity, Older People, Older People Supported and Involved in Decisions About Medicines, Older People With Complex Needs, Older People's Care, Opioid Painkillers, Opioids, Optimising Prescribing and Deprescribing in Older Adults, Over-Medication, Over-Prescribing, Over-Treatment, Overdiagnosis and Overtreatment, Overmedicalization, Overmedicaton in Care Homes, Overprescribing, Overprescription, Overuse of Medication, Owen’s Steps, Patient Harms, Patient Preference and Adherence, Patient Safety, Patients With Polypharmacy Risks, People With Dementia Living at Home, Pharmacist-Led Care Home Medication Reviews, Pharmacist-Led Home Medication Reviews, Pharmacist-Led Information Technology Intervention (PINCER), Pharmacist-Led Medication Reviews, Pharmacists, Pharmacists to Cut Unnecessary Hospital Admissions, PINCER, PINCER Intervention, PMDRP, Polypharmacy, Polypharmacy and Frailty, Polypharmacy in the Elderly STOPP and START Criteria, Poor Medicines Management, Potentially Inappropriate Medications (PIMs), Potentially Inappropriate Medications in the Elderly: the PRISCUS List, Potentially Inappropriate Medicine Combinations, Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Older People With Dementia, Prescribing Cascades, Prescribing Optimisation Method, Prescription Drugs, Prescription Drugs Dependency, Prescription Drugs: Long-Term Use, Prescription of Psychotropic Drugs, Prevalence of Potentially Inappropriate Prescribing in Older People With Dementia, Preventable Hospital Admissions, Preventative Care, Preventing Acute Admissions from Care Homes, Prevention, Prevention of Avoidable Emergency Admissions: Proactive Management of Long-Term Conditions, Preventive Care, Primary Care, Primary Care Adverse Drug Reactions, PRISCUS List, Proactive Specialist In-Reach, Professor Paul Cosford: Director for Health Protection and Medical Director at Public Health England, Protecting Resources and Promoting Value, Psychotropic Drug Cessation, Psychotropic Drugs, Public Health England, Rancourt Criteria, Reducing Inappropriate Polypharmacy, Reducing Prescribing Costs, Reducing Unplanned Hospital Admissions, Reducing Waste in the NHS, Reducing Wasted Medications, Robertson’s Flow Charts, Royal College of Physicians, School of Preventive Medicine and Public Health: Hanoi Medical University, Sloane List, Social Prescribing, Social Prescribing Approach to Reducing Default to Medicines / Drug-Based Treatments, South London and Maudsley NHS Mental Health Foundation Trust, START Criteria, STOPP and START Criteria, STOPP Criteria, STOPP START Criteria, Suboptimal Prescribing, Summary Care Records, Summary Care Records (SCRs), Sustainability, Sustainability in the NHS, Thinking Like a Patient and Acting Like a Taxpayer, TIMER Tool, Too Much Medicine, Tools for Measuring Potentially Inappropriate Prescribing in Older People With Dementia, Transforming Care for Frail Older People, United States, University of California Los Angeles, University of Hull, Unnecessary Hospital Admissions, Unsafe Drug Combinations, USA. Fielding School of Public Health: University of California Los Angeles, Value for Money, Value Improvement, Vietnam, Wellbeing in Care Homes, Wolfson Centre for Palliative Care Research: University of Hull, Z-Drugs (Sleeping Tablets), Zhan Criteria
|
Leave a comment
System to Measure and Prevent Medication Errors Under Development (Department of Health and Social Care / EEPRU / BBC News)
Summary The Department of Health and Social Care now has a system to help identify, monitor and prevent medication errors. The aim is to help ensure the NHS becomes the safest healthcare system in the world, as well as avoiding … Continue reading →
Posted in Acute Hospitals, Commissioning, Community Care, Department of Health, Department of Health and Social Care (DHSC), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest, World Health Organization (WHO)
|
Tagged Adverse Drug Reactions, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Avoidable Admissions, Avoidable Harm, Avoidable Hospital Admissions, Avoidable Ill-Health, Avoidable Mortality, Avoidable Premature Mortality, Avoidable Rehospitalisations, Caroline Dinenage: Care Minister, Choosing Wisely, Choosing Wisely Campaign, Community Pharmacists, Continuous Learning Culture, Culture Change, Culture of Raising Concerns, Defences for Pharmacists: Accidental Dispensing Errors, Department of Health and Social Care (Formerly the Department of Health), Electronic Prescribing and Medicines Administration (EPMA), Electronic Prescribing Systems, ePACT2, Epidemiology and Statistics, Gastric Bleed Statistics, Global Patient Safety Challenge (WHO), Hospital Admissions, Hospital Electronic Prescribing and Medicines Administration (HePMA), Inappropriate Hospital Admissions, Learning Culture, Measurement and Prevention of Medication Errors, Medication Errors, Medication Errors and Adverse Drug Reactions, Medication Reviews, Medication Safety, Medication Safety Dashboard, Medication Without Harm (WHO), Medicines Optimisation, Medicines Optimisation Dashboard, Medicines Safety Programme (WHO), NHS Culture Change, NHS England Medicines Optimisation Intelligence Group, NHS Patient Safety Culture, NHS Specialist Pharmacy Service, NHS: Safest Healthcare System in the World (Ambition), No Harm Culture, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Without Gastro Protective Medicine, Openness and Honesty When Things Go Wrong, Openness and Transparency, Patient Safety, Patient Safety Improvement, Patient Safety Indicators, Patient Safety Strategies, Patients With Polypharmacy Risks, Pharmacist-Led Medication Reviews, Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU), Polypharmacy, Preventable Deaths in English Acute Hospitals, Preventable Hospital Admissions, Preventable Hospital Deaths, Preventable Hospital Mortality, Preventable Mortality, Preventing Avoidable Emergency Admissions, Primary Care Adverse Drug Reactions, Putting Patients First, Quality Improvement, Quality Improvement Culture, Reducing Inappropriate Polypharmacy, Reducing Litigation Costs, Reducing Waste in the NHS, Regular Medication Reviews, Report of the Short Life Working Group on Reducing Medication-Related Harm, Reporting Culture, Reporting of Incidents, Research on Medication Error, Royal Pharmaceutical Society (RPS), ScHARR: University of Sheffield, School of Health and Related Research (ScHARR): University of Sheffield, Short Life Working Group on Reducing Medication-Related Harm, Stop the Over-Medication of People With a Learning Disability or Autism (STOMP) Campaign, Transparency, Transparency and Accountability, Transparent Learning Culture, Unnecessary Hospital Admissions
|
Leave a comment
Medication Errors: an Open Learning Culture Recommended to Reduce Patient Harm (BBC News / Department of Health / EEPRU / Department of Health and Social Care)
Summary Medication errors, which include (i) wrong medications given, (ii) incorrect doses and (iii) delays in medication being administered, cause an estimated 700 deaths per year and might play a role in something between 1,700 to 22,300 further avoidable deaths. … Continue reading →
Posted in Acute Hospitals, BBC News, Commissioning, Community Care, Department of Health, Department of Health and Social Care (DHSC), For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, Management of Condition, National, NHS, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest, World Health Organization (WHO)
|
Tagged Acute Care and Quality, Acute Care and Workforce, Adult Psychiatric Intensive Care Services, Adverse Drug Reactions, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, BBC Health News, Blame Culture, Care Home Culture, Care Home Environments, Care Homes, Centre for Health Economics: University of York, Choosing Wisely Campaign, Choosing Wisely in the NHS, CHUMS Study, Clinical Pharmacists, Clinical Responsibility for Patients (Choosing Wisely and New Deal), Community Pharmacists, Continuous Learning Culture, CQC Investigations and Quality Policy, Culture and Behaviour Change, Culture and Leadership, Culture Change, Culture of Raising Concerns, Department of Health Policy Research Programme, Division of Population Health Health Services Research and Primary Care: University of Manchester, Electronic Prescribing and Medicines Administration (EPMA), Electronic Prescribing Systems, EQUIP Study, Former Health Secretary Jeremy Hunt, Global Patient Safety Challenge (WHO), HePMA, Hospital E-Prescribing and Medicines Administration, Hospital Electronic Prescribing and Medicines Administration (HePMA), Hospital Pharmacists, Learning Culture, Making Choices Together (Previously Choosing Wisely Wales), Manchester Centre for Health Economics: University of Manchester, Medication Errors, Medication Errors and Adverse Drug Reactions, Medication Without Harm (WHO), Medicines Safety Programme (WHO), Medicines Value Programme (NHS England), NHS Culture, NHS Culture Change, NHS Patient Safety Culture, NHS Specialist Pharmacy Service, No Harm Culture, Old Age Psychiatry, Open and Transparent Culture, Openness, Openness and Collaboration, Openness and Honesty When Things Go Wrong, Openness and Transparency, Partnering with Patients and Families, Patient and Family Engagement, Patient and Public Engagement (PPE), Patient and Public Involvement, Patient and Public Involvement (PPI), Patient Engagement, Patient Engagement Strategies, Patient Harm, Patient Harms and Harm Free Care, Patient Safety, Patient Safety Champions, Patient Safety Improvement, Patient Safety Indicators, Patient Safety Strategies, Patients With Polypharmacy Risks, Pharmacist Buddy Scheme (County Durham and Darlington NHS Foundation Trust), Pharmacist-Led Information Technology Intervention (PINCER), Pharmacists, PINCER Intervention, Policy Research Programme (PRP), Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU), Polypharmacy, Potentially Preventable Complications in Hospitalis, PREPARE: Partnership for Responsive Policy Analysis and Research, PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) Study, Prescription Errors in Psychiatry, Preventable Deaths in English Acute Hospitals, Preventable Hospital Deaths, Preventable Hospital Mortality, Preventable Mortality, Primary Care Adverse Drug Reactions, PROTECT Programme, Putting Patients First, Quality Improvement Culture, Reducing Inappropriate Polypharmacy, Reducing Litigation Costs, Report of the Short Life Working Group on Reducing Medication-Related Harm, Reporting Culture, Reporting of Incidents, Research on Medication Error, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health and Social Care, ScHARR: University of Sheffield, School of Health and Related Research (ScHARR): University of Sheffield, SDM: Shared Decision Making, Secondary Care Adverse Drug Reactions, Serious Mistakes, Severe Harm, Shared Care and Education, Shared Decision-Making, Short Life Working Group (SLWG), Short Life Working Group on Reducing Medication-Related Harm, Stop the Over-Medication of People With a Learning Disability or Autism (STOMP) Campaign, Transparency, Transparency and Accountability, Transparent Learning Culture, UK Department of Health Policy Research Programme, United States National Coordinating Council for Medication Error Reporting and Prevention, University of Manchester, University of Sheffield, University of York, University of York Centre for Health Economics (CHE), WHO Domain: Health Care Professionals, WHO Domain: Medicines, WHO Domain: Patients and the Public, WHO Domain: Systems and Practice of Medication, WHO Domains, WHO Global Patient Safety Challenge
|
Leave a comment
Reducing Under-Usage of Medications (British Journal of Clinical Pharmacology)
Summary A meta-analysis investigating the impact of pharmaceutical care interventions for medication underuse in older people has shown that such interventions, including medication reviews, can reduce medication under-use in older people. Full Text Link Reference Meid, AD. Lampert, A. [and] … Continue reading →
Posted in Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, Systematic Reviews, Universal Interest
|
Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Ageing Population, Assessing Care of Vulnerable Elderly (ACOVE), Assessment of Underutilization (AOU) Index, British Journal of Clinical Pharmacology, Clinical Pharmacists, Community Pharmacists, Cooperation Unit Clinical Pharmacy: University of Heidelberg, Department of Clinical Pharmacology and Pharmacoepidemiology: University of Heidelberg, Germany, Good Prescribing, Medication Errors and Adverse Drug Reactions, Medication Reviews, Medication Underuse in Older People, Medication-Related Problems in the Elderly, Medications Under-Use, Optimisation of Pharmacotherapy in Older People, Pharmacist-Led Medication Reviews, Pharmacists, Polypharmacy in the Elderly STOPP and START Criteria, Potentially Inappropriate Prescribing (PIP), Reducing Under-Usage of Medications, School of Pharmacy: University of Colorado Anschutz Medical Campus, Screening Tool to Alert Doctors to Right Treatments (START), STOPP (Screening Tool of Older Person's Prescriptions), STOPP and START Criteria, Sub-Optimal Prescribing in Older Inpatients and Outpatients, Systematic Reviews and Meta-Analyses, Under-Usage of Medications, Undermedication, United States, University of Colorado, University of Heidelberg, USA
|
Leave a comment
Aspirin: Stomach Bleeds Risk for Over-75s (BBC News / Lancet / NHS Choices)
Summary Persons aged over 75 taking daily aspirin following a stroke or heart attack are at higher risk of stomach bleeds than thought previously. The benefits of low dose aspirin still outweigh the risks, even in this age group. Co-prescription … Continue reading →
Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged adverse, Adverse Drug Events, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Adverse Events, Aspirin, Aspirin: Low-Dose Acetylsalicylic Acid, Aspirin: Stomach Bleeds Risk for Over-75s, BBC Health News, Behind the Headlines, Centre for Prevention of Stroke and Dementia: University of Oxford, Daily Low-Dose Aspirin, Gastrointestinal Bleeding, John Radcliffe Hospital, Lancet, Nuffield Department of Clinical Neurosciences: University of Oxford, Oxford Vascular Study, Oxford Vascular Study (OXVASC), Prophylactic Use of Aspirin, Proton Pump Inhibitors (PPIs), University of Oxford
|
Leave a comment
Patient Safety Improvement in Care Homes (BMC Health Services Research)
Summary A programme to improve patient / resident safety in care homes is to be conducted in Walsall and Wolverhampton over 24 months. This article outlines the evaluation of this care home improvement programme in the West Midlands. The aim is … Continue reading →
Posted in Commissioning, Community Care, Falls, Falls Prevention, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest, Wolverhampton
|
Tagged Adverse Drug Reaction / Error Champions, Adverse Drug Reactions, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Safety Events, Avoidable Acute Hospital Admission in Older People, BMC Health Services Research, Care Home Culture, Care Home Environments, Care Homes, Changes in Safety Practices (Care Home Level), Changes in Safety Practices (Staff Level), CLAHRCs: NIHR Collaborations for Leadership in Applied Health Research and Care, Collaboration for Leadership in Applied Health Research and Care (CLAHRC), College of Medical and Dental Sciences: University of Birmingham, Culture of Safety, Dementia Education, Dementia Training, Education and Training, Hospital Activity, Improving Patient Safety, Inappropriate Hospital Admissions, Infection Control, Institute of Applied Health Research: University of Birmingham, Institute of Health Professions: University of Wolverhampton, Local AHSNs, Local Patient Safety Collaboratives, Medication Errors, Meridian Online Health Innovation Exchange, NHS England's Sign Up to Safety Campaign, NHS Walsall CCG, NHS Wolverhampton CCG, NIHR CLAHRC West Midlands, Opportunities to Treat Patients Without Hospital Admission, Patient Safety, Patient Safety Collaborative Programmes, Patient Safety Collaboratives, Patient Safety Collaboratives Programme, Positive Approaches to Care (PAC), Pressure Ulcers, Pressure Ulcers: Prevention, Preventable Hospital Admissions, Primary Health Care (Journal), Quality and Safety Improvement Approaches in Care Homes, Quality Improvement, Quality of Life for People Living in Care Homes, Research in Care Homes, Safer Provision and Caring Excellence (SPACE) Programme, Safety Attitudes Questionnaire (SAQ), Safety Improvement in Care Homes, Sign up to Safety, Sign Up to Safety Campaign, Skills and Training, SPACE Programme (WMAHSN), Staff Training, Training and Support, Transfer of Medicines, University of Birmingham, University of Wolverhampton, Unnecessary Hospital Admissions, Unplanned Hospital Admissions, Urinary Tract Infections (UTIs), Walsall, Walsall and Wolverhampton Care Home Improvement Programme, Walsall and Wolverhampton Clinical Commissioning Groups (CCGs), Wellbeing in Care Homes, West Midlands, West Midlands Patient Safety Collaborative (PSC), Wolverhampton, Workforce Competencies, Workforce Training
|
Leave a comment
Introducing the Journal of Geriatric Care and Research (JGCR)
Summary The Journal of Geriatric Care and Research (ISSN 2397-5628) is a recently launched, locally edited, multi-disciplinary peer-reviewed international journal, which covers topics of relevance to the care of the elderly. Concerning Guidelines on the Use of Antipsychotics for Agitation … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, International, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Pharmacological Treatments, Quick Insights, Wales, Wolverhampton
|
Tagged Academia.edu, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Agitation, Agitation and Aggression, Alternatives to Antipsychotics, Alzheimer’s Disease-Related Agitation, American Journal of Psychiatry, American Psychiatric Association (APA), American Psychiatric Association: Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia (2016), Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, APA Practice Guidelines, Aripiprazole, Atypical Antipsychotics, Avoidable Harm, Avoidable Hospital Mortality, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Benefits and Risks of Antipsychotic Treatment, Betsi Cadwaladr University Health Board, Black Country, Black Country Partnership NHS Foundation Trust, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Indian Psychiatric Association (BIPA), Community and Mental Health Trusts, Dr Sarmishtha Bhattacharyya: Consultant in Old Age Psychiatry at Wrexham Maelor Hospital, Faculty of Health and Social Care: University of Chester, Geriatric Care and Research Organisation (GeriCaRe), Haloperidol, Improving Prescribing Practice, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Journal of Geriatric Care and Research (JGCR), Learning Disabilities, Medication Reviews, Mental Health Trusts, North Wales, Olanzapine, Over-Medication, Over-Medication for People With Learning Disabilities, Over-Prescribing, Overprescribing, People With Learning Disabilities, Personalised Care Versus Guideline-Based Care, Personalised Medicine Versus Guideline-Based Medicine, Potential Harms of Antipsychotic Use, Potentially Inappropriate Prescribing, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Prescribing of Antipsychotic Drugs For People With Learning Disabilities, Psychosis in Patients With Dementia, Quetiapine, Reducing Agitation and Distress, Reducing Antipsychotic Prescriptions in Dementia, Reducing Avoidable Premature Mortality, Reducing Inappropriate Use of Antipsychotics, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Safe and Compassionate Care, United States, University of Chester, USA, Violence and Aggression, West Midlands, Wrexham, Wrexham Maelor Hospital, Ziprasidone
|
Leave a comment
Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA / JAMA Psychiatry / BJCP)
Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, Statistics, UK
|
Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions (ADRs): Type A (Potentially Avoidable and Associated With Commonly Prescribed Medications), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Alternatives to Antipsychotics, Antidepressants, Antihypertensives, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Absolute Mortality Risk Increase, Antipsychotics: Neuroleptic Sensitivity, Antipsychotics: Number Needed to Harm (NNH), Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Benzodiazepines, BMJ, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brief Psychosocial Treatment, British Journal of Clinical Pharmacology, British Medical Journal (BMJ), Campbell Institute (CAMH): University of Toronto, Cardiff University, Center for Clinical Management Research: Veterans Affairs Ann Arbor Healthcare System (Michigan), Center for Statistical Consultation and Research: University of Michigan, CitAD Research Group, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Clinical Biotechnology Research Institute: Roper St Francis Healthcare (Charleston: South Carolina), College of Physicians and Surgeons of Columbia University, DART-AD: Dementia Antipsychotic Withdrawal Trial (DART-AD), Dementia Antipsychotic Withdrawal Trial (DART-AD), Department of Psychiatry: University of Michigan, Department of Psychiatry: University of Southern California, Discontinuation of Antipsychotics, Effect of Citalopram on Agitation in Alzheimer Disease (CitAD Randomized Clinical Trial), Falls Prevention, Hotchkiss Brain Institute: University of Calgary, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, International Conference on Harmonization, JAMA, JAMA Psychiatry, Johns Hopkins Bayview and Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health: Baltimore, Kings College London, Medication Reviews, National Institute for Health Research (NIHR): Mental Health Biomedical Research Centre and Dementia Unit, NEST Approach, Neuroleptic Discontinuation, Neuroleptics, New York State Psychiatric Institute, Patients’ Needs and the Environment Stimulation and Techniques (NEST), Perelman School of Medicine: University of Pennsylvania, Personalised Social Interaction, Pharmacokinetics, Polypharmacy, Potential Harms of Antipsychotic Use, Prescribing Anti-Psychotic Drugs to People with Dementia, Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Seattle Protocols, Simulated Presence Therapy, South London and Maudsley NHS Foundation Trust, Stanford University School of Medicine, United States, University Hospital Llandough (Cardiff), University of Calgary, University of Manchester, University of Michigan, University of Pennsylvania, University of Rochester School of Medicine and Dentistry, University of Southern California, University of Southern California Keck School of Medicine, University of Toronto, Violence and Aggression, Wolfson Centre for Age-Related Diseases: King’s College London
|
Leave a comment
